Iridex (IRIX) Convertible Debt (2024 - 2026)
Iridex (IRIX) posted quarterly Convertible Debt of $3.8 million for Q2 2026, up 3.32% year-over-year from $3.6 million in Q2 2025, and up 0.8% quarter-over-quarter from $3.7 million in Q1 2026.
Iridex (IRIX) Convertible Debt (2024 - 2026) Analysis & Trends
Iridex's Convertible Debt history runs 3 years deep, the most recent figure standing at $3.8 million for Q2 2026.
- In Q2 2026, Convertible Debt rose 3.32% year-over-year to $3.8 million; the TTM figure through Apr 2026 stood at $3.8 million (up 3.32% YoY), while the FY2026 annual figure was $3.7 million, up 38.33% from the prior year.
- Convertible Debt for Q2 2026 stood at $3.8 million, up from $3.7 million in the prior quarter.
- The five-year high for Convertible Debt was $3.8 million in Q2 2026, with the low at $1.4 million in Q3 2024.
- The 3-year median for Convertible Debt is $3.7 million (2025), against an average of $3.2 million.
- The sharpest annual moves came in 2025 and 2026: Convertible Debt jumped 156.58% in 2025, then increased 3.32% in 2026.
- Iridex's Convertible Debt stood at $2.7 million in 2024, then surged by 37.22% to $3.7 million in 2025, then advanced by 1.62% to $3.8 million in 2026.
- Business Quant data shows IRIX's Convertible Debt at $3.8 million in Q2 2026, $3.7 million in Q1 2026, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Iridex | 13.09 Mn | 8.41 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 3.77 Mn |
| Jan 3, 2026 | 3.74 Mn |
| Sep 27, 2025 | 3.71 Mn |
| Jun 28, 2025 | 3.68 Mn |
| Mar 29, 2025 | 3.64 Mn |
| Dec 28, 2024 | 2.70 Mn |
| Sep 28, 2024 | 1.44 Mn |